Search Results (56)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Immunogenicity in Clinical Practice and Drug Development: When is it Significant? | Academic Article |
Why?
|
Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science. | Academic Article |
Why?
|
2019 Drug Metabolism Gordon Research Conference Guiding Drug Development Using Translational ADME Science | Grant |
Why?
|
Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond. | Academic Article |
Why?
|
Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research. | Academic Article |
Why?
|
Pediatric pharmacokinetics: human development and drug disposition. | Academic Article |
Why?
|
Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. | Academic Article |
Why?
|
Identifying genomic and developmental causes of adverse drug reactions in children. | Academic Article |
Why?
|
Developmental pharmacology--drug disposition, action, and therapy in infants and children. | Academic Article |
Why?
|
Developmental aspects of drug metabolism in children | Academic Article |
Why?
|
Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants. | Academic Article |
Why?
|
Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development. | Academic Article |
Why?
|
Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life. | Academic Article |
Why?
|
The role of CYP3A4 mRNA transcript with shortened 3'-untranslated region in hepatocyte differentiation, liver development, and response to drug induction. | Academic Article |
Why?
|
Ontogeny and Genetics of NSAID Dose-Exposure Relationship in Preterm Infants | Grant |
Why?
|